Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7T7B | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab | |
| 7T7B | 7T7B | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab | |
| 7T79 | P35557 | CRYSTAL STRUCTURE OF GLUCOKINASE (HEXOKINASE 4) COMPLEXED WITH LIGAND AKA DIETHYL {[3-(3-{[5-(AZETIDINE-1-CARBON YL)PYRAZIN-2-YL]OXY}-5-(PROPAN-2-YLOXY)BENZAMIDO)-1H- PYRAZOL-1-YL]METHYL}PHOSPHONATE | |
| 7T78 | P35557 | CRYSTAL STRUCTURE OF GLUCOKINASE (HEXOKINASE 4) COMPLEXED WITH LIGAND DIETHYL ({2-[3-(4-METHANESULFONYLPHENO XY)-5-{[(2S)-1-METHOXYPROPAN-2-YL]OXY}BENZAMIDO]-1,3-THIAZ OL-4-YL}METHYL)PHOSPHONATE | |
| 7T77 | 7T77 | HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab | |
| 7T76 | 7T76 | HIV-1 Envelope ApexGT3 in complex with PG9.iGL Fab | |
| 7T75 | 7T75 | HIV-1 Envelope ApexGT2 in complex with RM20A3 Fab | |
| 7T74 | 7T74 | HIV-1 Envelope ApexGT2 in complex with PCT64.35S Fab and RM20A3 Fab | |
| 7T73 | 7T73 | HIV-1 Envelope ApexGT2.2MUT in complex with PCT64.LMCA Fab | |
| 7T72 | P0DTC2 | Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients | |
| 7T72 | 7T72 | Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients | |
| 7T6X | 7T6X | Cryo-EM structure of full-length hepatitis C virus E1E2 glycoprotein in complex with AR4A, AT12009, and IGH505 Fabs | |
| 7T6X | A0A159UHX2 | Cryo-EM structure of full-length hepatitis C virus E1E2 glycoprotein in complex with AR4A, AT12009, and IGH505 Fabs | |
| 7T6W | G0SFD1 | Crystal structure of Chaetomium Glucosidase I (apo) | |
| 7T6I | Q95HB9 | Crystal structure of HLA-DP1 in complex with pp65 peptide in reverse orientation | |
| 7T6I | S6B6U4 | Crystal structure of HLA-DP1 in complex with pp65 peptide in reverse orientation | |
| 7T6I | P06725 | Crystal structure of HLA-DP1 in complex with pp65 peptide in reverse orientation | |
| 7T68 | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound UV-5 | |
| 7T67 | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up | |
| 7T66 | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound UV-4 | |
| 7T5E | Q8WZQ2 | Neutron structure of Neurospora crassa Polysaccharide Monooxygenase 9D (NcLPMO9D) low pH vapor exchange | |
| 7T5D | Q8WZQ2 | Neutron structure of Neurospora crassa Lytic Polysaccharide Monooxygenase 9D (NcLPMO9D) ascorbate soak | |
| 7T5C | Q8WZQ2 | X-ray structure of Neurospora crassa Polysaccharide Monooxygenase 9D (NcLPMO9D) at low pH | |
| 7T4S | F5H9T3 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4S | Q71DN9 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4S | Q38LY2 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4S | Q38M07 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4S | Q8AZ45 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4S | O60462 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4S | 7T4S | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11 | |
| 7T4R | P07204 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4R | F5H9T3 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4R | Q71DN9 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4R | Q38LY2 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4R | Q38M07 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4R | Q8AZ45 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4R | 7T4R | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11 | |
| 7T4Q | F5H9T3 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with neutralizing fabs 2C12, 7I13 and 13H11 | |
| 7T4Q | Q71DN9 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with neutralizing fabs 2C12, 7I13 and 13H11 | |
| 7T4Q | Q38LY2 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with neutralizing fabs 2C12, 7I13 and 13H11 | |
| 7T4Q | Q38M07 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with neutralizing fabs 2C12, 7I13 and 13H11 | |
| 7T4Q | Q8AZ45 | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with neutralizing fabs 2C12, 7I13 and 13H11 | |
| 7T4Q | 7T4Q | CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with neutralizing fabs 2C12, 7I13 and 13H11 | |
| 7T4G | A0A5C0E975 | The Envelope Glycoprotein SIVmac239.K180S SOSIP trimer in complex with 3 copies of the neutralizing antibody K11 | |
| 7T4G | L7XFX7 | The Envelope Glycoprotein SIVmac239.K180S SOSIP trimer in complex with 3 copies of the neutralizing antibody K11 | |
| 7T4G | 7T4G | The Envelope Glycoprotein SIVmac239.K180S SOSIP trimer in complex with 3 copies of the neutralizing antibody K11 | |
| 7T3M | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
| 7T3M | 7T3M | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
| 7T3E | Q6LPV9 | Structure of the sialic acid bound Tripartite ATP-independent Periplasmic (TRAP) periplasmic component SiaP from Photobacterium profundum | |
| 7T3D | C3W5S1 | CryoEM map of anchor 222-1C06 Fab and lateral patch 2B05 Fab binding H1 HA |
